PMDA drug package insert
ヒヤこども鼻炎薬AL
PMDA OTC drug · 樋屋奇応丸（株） · package insert Dec 13, 2024
Key facts
| Brand names | ヒヤこども鼻炎薬AL |
|---|---|
| Companies | 製造販売元／奥田製薬（株）,販売会社／樋屋奇応丸（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | 鼻炎用内服薬 |
| Package insert date | Dec 13, 2024 |
| PMDA document key | 180150_J2301000230 |
| PMDA company code | 180150 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: